NFKB1 and rheumatoid arthritis: Recent findings have revealed that NETs activate ATP-citrate lyase (ACLY) in RA-FLS, driving lipogenesis, cell proliferation, migration, invasiveness, and NF-κB-mediated inflammation, ultimately exacerbating synovial inflammation and joint damage in RA (39).